🩺 DRUGS FOR BENIGN PROSTATIC HYPERTROPHY 🏷️ Selective alpha-1 blocker/ selective 5 alpha-reductase inhibitor
👨‍⚕️ Clinically Reviewed by: PakistaniBano Medical Editorial Board (Pharm.D Panel)
📅 Reviewed: November 2026 • 🔍 Authority: DRAP / WHO ATC
📦 Formulations, Pack Sizes & Retail Prices Currency: Rs.
Dosage Form Reg. No Pack Size Trade Price (TP) Maximum Retail Price (MRP)
Cap 0.4/0.05 mg 090994 10 Rs.1440.75 Rs.1695.00

📋 Indications & Clinical Dosage

*Symptomatic treatment of benign prostatic hyperplasia (BPH):* Adults(male including elderly): One capsule taken once daily approximately 30 minutes after the same meal each day, as a single dose. Children: Not recommended.

⛔ Contraindications

Patients with known hypersensitivity to drug, women, children and adolescents, patients with a history of orthostatic hypotension, severe hepatic impairment.

⚠️ Precautions & Warnings

Since selective alpha-blockers reduce blood pressure, patients receiving antihypertensive treatment may require reduced dosage and specialist supervision, cardiovascular disease, caution required in patients with prostate cancer and high grade tumours, elderly and in patients with hepatic impairment and renal impairment. Caution required in cataract surgery (risk of intra-operative floppy iris syndrome).

🔄 Drug Interactions

Antihypertensives, strong Inhibitors of CYP3A4, inhibitors of CYP2D6 and moderate inhibitors of CYP3A4, Cimetidine, other alpha adrenergic antagonists, phosphodiesterase-5 Inhibitors (PDE-5 Inhibitors), warfarin

⚠️ Adverse Reactions / Side Effects

Dizziness, impotence, altered (decreased) libido, ejaculation disorders and breast disorders. Rare: Angioedema, Cardiac failure.

📚 Official Regulatory & Clinical References

  • Drug Regulatory Authority of Pakistan (DRAP): Drug Registration, S.R.O. Price Gazettes & National Essential Medicines List (NEML).
  • World Health Organization (WHO): Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index).
  • Formulary Standards: British National Formulary (BNF) & Pakistan National Formulary (PNF) guidelines.

Related Medicines

Medicines related to this brand, grouped by relevance.

Same generic: TAMSULOSIN HCl AND DUTASTERIDE

Rs.2970.00
Rs.900.00
TAMSOL-D
GLOBAL
Rs.Cap 0.4/0.05 mg
Rs.3900.00

More from GETZ

Rs.800.00
ADELA
GETZ
Rs.150.00
Rs.343.00
Rs.1,260.00
AGNAR
GETZ
Rs.491.45

Same category: DRUGS FOR BENIGN PROSTATIC HYPERTROPHY

ALFAMAX
PLATINUM
Rs.800.00
ALFATAM
LINTA
Rs.774.67
Rs.2000.00

⚡ Quick Actions

💬 Share via WhatsApp